US Edition
EuroPCR 2025 hears early outcomes of Topaz TTVR system - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
EuroPCR 2025 hears early outcomes of Topaz TTVR system - Cardiovascular News
Julien Dreyfus TRiCares has announced the presentation of data in a late-breaking session at EuroPCR 2025 (20–23 May, Paris, France) from its first-in-human trial of the Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, France) presented 30-day post-procedural data from 20 tricuspid regurgitation (TR) patients treated with Topaz across eight specialist cardiac centres in Eur…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
